-  - Zm. - Wolumen Bid- Ask- Kapitalizacja Rynkowa St. dywidendy Wskaźnik C/Z
-USD - -
Obrót: -
-Wolumen Bid: - -Wolumen Ask: - 4,08 mldUSD - -

Opis działalności

Dottikon ES Holding AG manufactures high-quality performance chemicals, intermediates and exclusive active pharmaceutical ingredients (APIs) for the world's leading chemical and pharmaceutical industry. The company with its production site in Dottikon (Aargau, Switzerland) is specialized in hazardous reactions and is positioning itself as strategic development and manufacturing partner. Its safety culture created over the last 100 years guides innovative uses of hazardous reactions, low-temperature and high-pressure chemistry, as well as continuous processing. This shortens conventional chemical synthesis routes, increases yields, selectivities and purities, and reduces waste. The versatile technology and equipment portfolio is used to design, develop and optimize chemical processes, and scale up from kilograms to multi-tons. The technology portfolio is built around active pharmaceutical ingredients (APIs) and performance chemicals and comprises hazardous reactions, low-temperature and high-pressure reactions as well as continuous processing.
 

Zarząd & Rada nadzorcza

CEO
Dr. Markus Blocher
Zarząd
Marlene Born, Karin Krause, Dr. Stephan Kirschbaum, Dr. Urs Brändli, Dr. Thomas Rosatzin, Dr. Robert Dahinden, Dr. Rolf Schaller
Rada nadzorcza
Dr. Markus Blocher, Dr. Pierre-Alain Ruffieux, Dr. Bernhard Urwyler
 

Dane firmy

Nazwa: Dottikon ES Holding AG
Adres: Hembrunnstrasse 17,CH-5605 Dottikon
Telefon: +41-56-616-8111
Fax: -
E-mail: info@dottikon.com
Internet: www.dottikon.com
Przemysł: Surowce naturalne
Sektor: Chemia
Podsektor: Chemia, Zróżnicowana
Koniec roku finansowego: 31.03
Free float: 16,20%
Data IPO: -

Relacje inwestorskie

Nazwa: Marlene Born
Telefon: +41-56-616-8201
Fax: -
E-mail: investor-relations@d...kon.com investor-relations@dottikon.com

Główni akcjonariusze

Markus Blocher
 
64,74%
Inne
 
19,96%
Peter Grogg
 
7,00%
Miriam Baumann
 
5,10%
UBS Fund Management AG
 
3,20%